BlackRock Health Sciences Term Trust (BMEZ)
BlackRock Health Sciences Term Trust (BMEZ) is listed on the New York Stock Exchange.
- Listed On
- the New York Stock Exchange
- Market Cap
- $1.0B
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
Institutional ownership
In 13F filings for the quarter ended September 30, 2026, 2 institutions reported holding BMEZ, with 26,320 shares worth $439,545 in aggregate. The largest reported holder was Chapin Davis, with 25,120 shares worth $419,505. Of the 2 largest holders listed below, 1 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Chapin Davis | 25,120 | $420K | Reduced 5.04% |
| Corecap Advisors | 1,200 | $20K | Added 20% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BMEZ?
BlackRock Health Sciences Term Trust (BMEZ) is listed on the New York Stock Exchange.
Who are the largest institutional holders of BMEZ?
In 13F filings for the quarter ended September 30, 2026, the largest reported holders of BMEZ were Chapin Davis and Corecap Advisors.
How many institutions own BMEZ?
2 institutions reported a position in BMEZ for the quarter ended September 30, 2026, worth $439,545 in total.
Did institutions buy or sell BMEZ last quarter?
Of the 2 largest reported holders, 1 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for BMEZ.
Every reported institutional holder, plus insider and congressional trades in BMEZ, on SentiSense.